These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10850292)

  • 1. Preparation and in vitro studies of [125I]IUDR-T101 antibody conjugate.
    Chakrabarti MC; Paik CH; Carrasquillo JA
    Cancer Biother Radiopharm; 1999 Apr; 14(2):91-8. PubMed ID: 10850292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5-mediated specific delivery of DNA to T lymphocytes: compartmentalization augmented by adenovirus.
    Merwin JR; Carmichael EP; Noell GS; DeRome ME; Thomas WL; Robert N; Spitalny G; Chiou HC
    J Immunol Methods; 1995 Oct; 186(2):257-66. PubMed ID: 7594625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective cytotoxicity of 125I-labeled monoclonal antibody T101 in human malignant T cell lines.
    Boven E; Lindmo T; Mitchell JB; Bunn PA
    Blood; 1986 Feb; 67(2):429-35. PubMed ID: 2417645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cellular catabolism of 111In, 90Y and 125I radiolabeled T101 anti-CD5 monoclonal antibody.
    Naruki Y; Carrasquillo JA; Reynolds JC; Maloney PJ; Frincke JM; Neumann RD; Larson SM
    Int J Rad Appl Instrum B; 1990; 17(2):201-7. PubMed ID: 1692819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of radiolysis of monoclonal antibody during labeling.
    Chakrabarti MC; Le N; Paik CH; De Graff WG; Carrasquillo JA
    J Nucl Med; 1996 Aug; 37(8):1384-8. PubMed ID: 8708780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.
    Foss FM; Raubitscheck A; Mulshine JL; Fleisher TA; Reynolds JC; Paik CH; Neumann RD; Boland C; Perentesis P; Brown MR; Frincke JM; Lollo CP; Larson SM; Carrasquillo JA
    Clin Cancer Res; 1998 Nov; 4(11):2691-700. PubMed ID: 9829731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative cellular catabolism and retention of astatine-, bismuth-, and lead-radiolabeled internalizing monoclonal antibody.
    Yao Z; Garmestani K; Wong KJ; Park LS; Dadachova E; Yordanov A; Waldmann TA; Eckelman WC; Paik CH; Carrasquillo JA
    J Nucl Med; 2001 Oct; 42(10):1538-44. PubMed ID: 11585870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic modulation by anti-CD5 immunotoxins.
    Manske JM; Buchsbaum DJ; Azemove SM; Hanna DE; Vallera DA
    J Immunol; 1986 Jun; 136(12):4721-8. PubMed ID: 3086441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of in vitro and in vivo antigenic modulation by the anti-human T-cell monoclonal antibody T101.
    Shawler DL; Miceli MC; Wormsley SB; Royston I; Dillman RO
    Cancer Res; 1984 Dec; 44(12 Pt 1):5921-7. PubMed ID: 6333922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma.
    Carrasquillo JA; Mulshine JL; Bunn PA; Reynolds JC; Foon KA; Schroff RW; Perentesis P; Steis RG; Keenan AM; Horowitz M
    J Nucl Med; 1987 Mar; 28(3):281-7. PubMed ID: 3102699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor uptake and mitotic activity pattern of 5-[125I]iodo-2'- deoxyuridine after intravesical infusion in patients with bladder cancer.
    Mariani G; Collecchi P; Baldassarri S; Di Luca L; Buralli S; Fontanini G; Baranowska-Kortylewicz J; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Apr; 37(4 Suppl):16S-19S. PubMed ID: 8676197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusion of T101 monoclonal antibody in chronic lymphocytic leukemia and cutaneous T-cell lymphoma.
    Dillman RO; Beauregard J; Shawler DL; Halpern SE; Markman M; Ryan KP; Baird SM; Clutter M
    J Biol Response Mod; 1986 Oct; 5(5):394-410. PubMed ID: 3490543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiododeoxyuridine in cancer therapy: an in vitro approach to developing in vivo strategies.
    Schneiderman MH; Schneiderman GS
    J Nucl Med; 1996 Apr; 37(4 Suppl):6S-9S. PubMed ID: 8676203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
    Press OW; Shan D; Howell-Clark J; Eary J; Appelbaum FR; Matthews D; King DJ; Haines AM; Hamann P; Hinman L; Shochat D; Bernstein ID
    Cancer Res; 1996 May; 56(9):2123-9. PubMed ID: 8616860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
    Weil-Hillman G; Runge W; Jansen FK; Vallera DA
    Cancer Res; 1985 Mar; 45(3):1328-36. PubMed ID: 3971376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire.
    Neshasteh-Riz A; Mairs RJ; Angerson WJ; Stanton PD; Reeves JR; Rampling R; Owens J; Wheldon TE
    Br J Cancer; 1998; 77(3):385-90. PubMed ID: 9472632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
    Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM
    Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune interferon modulation of in vitro murine anti-human T cell monoclonal antibody-mediated cytotoxicity.
    Dillman RO; Johnson DE; Shawler DL
    J Immunol; 1986 Jan; 136(2):728-31. PubMed ID: 3079792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotoxicity of 125I in mammalian cells.
    Kassis AI; Fayad F; Kinsey BM; Sastry KS; Taube RA; Adelstein SJ
    Radiat Res; 1987 Aug; 111(2):305-18. PubMed ID: 3628718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of human CD5 modulation and capping induced by murine monoclonal antibody T101.
    Shawler DL; Johnson DE; McCallister TJ; Bartholomew RM; Dillman RO
    Clin Immunol Immunopathol; 1988 May; 47(2):219-29. PubMed ID: 3258212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.